Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain
Clinical trial NCT05561023 · UNKNOWN
Trial details
- NCT number
- NCT05561023
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-09-30
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.